Biological E Corbevax vaccine gets WHO Emergency Use Listing authorisation - Video
|
Overview
Biological E. Limited, a Hyderabad-based Vaccines and Pharmaceutical company, has announced that the World Health Organisation (WHO) has granted an Emergency Use Listing (EUL) to their CORBEVAX vaccine, which is India's first indigenously developed COVID-19 vaccine that is based on protein sub-unit platform.
For the full story, check out the link given below:
WHO Grants Emergency Use Listing To Biological E Corbevax Vaccine
Speakers
Roshni Dhar, a Mass com graduate with a soft corner for health happenings, joined Medical Dialogues as a news anchor in 2021. Inspired by her mother who is a gynaecologist, she likes to keep herself and the world updated on the occurring in the medical field. She covers various aspects of health news for MDTV at Medical Dialogues. She can be contacted at editorial@medicaldialogues.in. Contact no. 011-43720751
